Urgent Management and Diagnostic Work-Up
This elderly male with dyspnea, macrocytic anemia, elevated RDW, and neutrophilia requires immediate evaluation for myelodysplastic syndrome (MDS) with urgent hematology referral and bone marrow biopsy, while simultaneously addressing acute cardiopulmonary causes of his dyspnea.
Immediate Stabilization and Assessment
The combination of macrocytosis with high RDW (indicating significant anisocytosis) and neutrophilia in an elderly patient with dyspnea raises critical red flags. First, stabilize oxygenation and assess for acute cardiopulmonary emergencies (heart failure, pneumonia, pulmonary embolism). However, the hematologic picture strongly suggests an underlying bone marrow disorder.
Key Diagnostic Priorities
The macrocytosis with elevated RDW and neutrophilia in an elderly patient is highly suspicious for MDS 1. While macrocytic anemia has multiple causes—including vitamin B12/folate deficiency, alcohol, liver disease, hypothyroidism, and medications 2, 3—the presence of neutrophilia alongside macrocytosis shifts the differential heavily toward a myeloid neoplasm.
Algorithmic Diagnostic Approach
Step 1: Peripheral Blood Smear Review (Urgent)
- Look specifically for:
- Macro-ovalocytes and teardrop cells (suggest megaloblastic process or MDS) 2
- Dysplastic neutrophils (hyposegmented or hypersegmented)
- Circulating blasts (mandates immediate hematology consultation)
- Anisocytosis pattern (high RDW confirms this)
Step 2: Initial Laboratory Panel (Same Day)
- Vitamin B12 and folate levels (megaloblastic causes account for <10% of macrocytosis but must be excluded) 2
- Methylmalonic acid and homocysteine if B12 is borderline (more sensitive for true deficiency) 2
- Liver function tests (liver disease is a common cause of macrocytosis) 2, 3
- TSH (hypothyroidism screening) 3
- Reticulocyte count (assess bone marrow response; low count suggests production problem)
- LDH and indirect bilirubin (exclude hemolysis)
Step 3: Hematology Referral (Within 24-48 Hours)
When MDS is suspected along with leukocytopenia and/or thrombocytopenia with anemia, hematology consultation is appropriate 1. In this case, even without documented leukopenia or thrombocytopenia, the combination of macrocytosis, high RDW, and neutrophilia in an elderly patient warrants urgent hematology evaluation.
Step 4: Bone Marrow Examination
Bone marrow aspirate and biopsy with cytogenetic analysis is required when MDS is suspected 4, 5. This is particularly critical in elderly patients where MDS prevalence is highest 1. The bone marrow evaluation should include:
- Morphologic assessment for dysplasia
- Blast percentage
- Cytogenetic analysis (essential for IPSS-R risk stratification and detecting del(5q))
- Flow cytometry if available
Critical Pitfalls to Avoid
Do not assume nutritional deficiency without confirmation: While B12/folate deficiency is easily treatable, empiric supplementation without testing can mask MDS diagnosis 1, 3.
Do not delay bone marrow biopsy if initial labs are unrevealing: In elderly patients with unexplained macrocytic anemia and cytopenias, MDS remains high on the differential even with normal B12/folate 1, 6.
MCV >120 fL typically indicates B12 deficiency 2, but values of 100-120 fL are more commonly drug-related, alcohol-related, or due to MDS in hospitalized elderly patients.
The neutrophilia is concerning: While reactive neutrophilia from infection is possible (given dyspnea), neutrophilia in the context of macrocytic anemia and high RDW suggests a myeloproliferative component that requires bone marrow evaluation.
Risk Stratification Context
If MDS is confirmed, IPSS-R scoring will guide treatment decisions 4, 5. Lower-risk MDS with symptomatic anemia may respond to erythropoiesis-stimulating agents (ESAs) if serum erythropoietin ≤500 mU/mL, or lenalidomide if del(5q) is present 5. Higher-risk disease requires consideration of hypomethylating agents (azacitidine, decitabine) or allogeneic stem cell transplant in select patients 4, 5.
Addressing the Dyspnea
While pursuing hematologic workup, the dyspnea requires parallel evaluation:
- Chest imaging (if not already done)
- BNP/troponin (cardiac causes)
- Consider that even mild anemia compromises well-being and survival in elderly patients 7, and the dyspnea may be multifactorial (anemia plus cardiopulmonary disease)
The urgency stems from the fact that MDS commonly affects the elderly 1, and early diagnosis allows for risk-appropriate therapy that can improve survival in higher-risk disease 4 or quality of life through targeted anemia management in lower-risk disease 5.